| EP4445899 - SUSTAINED RELEASE DOSAGE FORMS COMPRISING COMPLEXES OF LOW SOLUTIBILITY COMPOUNDS, AND METHODS FOR THEIR PREPARATION [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 13.09.2024 Database last updated on 10.03.2026 | Most recent event Tooltip | 18.04.2025 | Amendment by applicant | Applicant(s) | For all designated states Emoviar PharmaCon GmbH Merianstraße 53 79664 Wehr / DE | For all designated states Scheer, Mathias Josef Mozartstraße 9 79664 Wehr / DE | [2024/42] | Inventor(s) | 01 /
Scheer, Mathias Josef 79664 Wehr / DE | [2024/42] | Representative(s) | CH Kilger Anwaltspartnerschaft mbB Fasanenstraße 29 10719 Berlin / DE | [2024/42] | Application number, filing date | 24163798.2 | 15.03.2024 | [2024/42] | Priority number, date | EP20230167874 | 13.04.2023 Original published format: EP 23167874 | [2024/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP4445899 | Date: | 16.10.2024 | Language: | EN | [2024/42] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 20.06.2024 | Classification | IPC: | A61K9/50, A61K47/69, A61K31/496, A61K47/40, A61K9/20 | [2024/42] | CPC: |
A61K47/40 (EP,US);
A61K31/496 (EP,US);
A61K47/6951 (EP);
A61K9/2077 (EP);
A61K9/5047 (EP);
A61K9/5078 (EP);
A61K9/5042 (EP)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/42] | Extension states | BA | Not yet paid | Validation states | GE | Not yet paid | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | DOSIERUNGSFORMEN MIT VERZÖGERTER FREISETZUNG FÜR VERBINDUNGEN MIT GERINGER LÖSLICHKEIT UND VERFAHREN ZUR HERSTELLUNG DIESER DOSIERUNGSFORMEN MIT VERZÖGERTER FREISETZUNG | [2024/42] | English: | SUSTAINED RELEASE DOSAGE FORMS COMPRISING COMPLEXES OF LOW SOLUTIBILITY COMPOUNDS, AND METHODS FOR THEIR PREPARATION | [2024/42] | French: | FORMES POSOLOGIQUES À LIBÉRATION PROLONGÉE POUR COMPOSÉS À FAIBLE SOLUBILITÉ ET PROCÉDÉS DE PRÉPARATION DE CES FORMES POSOLOGIQUES À LIBÉRATION PROLONGÉE | [2024/42] | Examination procedure | 15.03.2024 | Examination requested [2024/42] | 16.04.2025 | Amendment by applicant (claims and/or description) | 16.04.2025 | Date on which the examining division has become responsible |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X] CN108697808 (COUNCIL SCIENT IND RES et al.) | [X] CN104546724 (BORUI BIOMEDICAL TECHNOLOGY SUZHOU CO LTD et al.) [X] 1-12 * claims 1,4,6,10,15 * * examples 1,2 * * figure 9 * | [X] US2018250262 (RENWICK JEFF et al.) [X] 1-12 * claims 1-10 * * examples 1-14 * * figures 2,3 * | [X] US2016175229 (DELALANDE CHARLOTTE et al.) [X] 1-12 * claims 1,14,15 * * examples 1-10 * * paragraph [0077] * | by applicant | J. PHARM. SCI., vol. 64, 1975, pages 1585 |